Circulating miR-126-3p and miR-423-5p Expression in de novo Adult Acute Myeloid Leukemia: Correlations with Response to Induction Therapy and the 2-Year Overall Survival

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.21654
   PubMed Web of Science ®Google Scholar
• Grove CS, Vassiliou GS. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? Dis Model Mech. 2014;7(8):941–951. doi:10.1242/dmm.015974
   PubMed Web of Science ®Google Scholar
• Heneghan HM, Miller N, Kerin MJ. MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol. 2010;10(5):543–550. doi:10.1016/j.coph.2010.05.010
   PubMed Web of Science ®Google Scholar
• Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47(D1):D155–D62. doi:10.1093/nar/gky1141
   PubMed Web of Science ®Google Scholar
• O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402. doi:10.3389/fendo.2018.00402
   PubMed Web of Science ®Google Scholar
• Sohel MH. Extracellular/circulating microRNAs: release mechanisms, functions and challenges. Achievements Life Sci. 2016;10(2):175–186. doi:10.1016/j.als.2016.11.007
   Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513–10518. doi:10.1073/pnas.0804549105
   PubMed Web of Science ®Google Scholar
• Nikolic I, Plate KH, Schmidt MHH. EGFL7 meets miRNA-126: an angiogenesis alliance. J Angiogenes Res. 2010;2(1):9. doi:10.1186/2040-2384-2-9
   PubMedGoogle Scholar
• Feng R, Chen X, Yu Y, et al. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett. 2010;298(1):50–63. doi:10.1016/j.canlet.2010.06.004
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang B, Wang HY, Chang A, Zheng XFS. Emerging role of MicroRNAs in mTOR signaling. Cell Mol Life Sci. 2017;74(14):2613–2625. doi:10.1007/s00018-017-2485-1
   PubMed Web of Science ®Google Scholar
• de Leeuw DC, Denkers F, Olthof MC, et al. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res. 2014;74(7):2094–2105. doi:10.1158/0008-5472.CAN-13-1733
   PubMed Web of Science ®Google Scholar
• Ke R, Lv L, Zhang S, Zhang F, Jiang Y. Functional mechanism and clinical implications of MicroRNA-423 in human cancers. Cancer Med. 2020;9(23):9036–9051. doi:10.1002/cam4.3557
   PubMed Web of Science ®Google Scholar
• Ng EK, Chong WW, Jin H, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009;58(10):1375–1381. doi:10.1136/gut.2008.167817
   PubMed Web of Science ®Google Scholar
• miRCURY LNA miRNA PCR Handbook. Qiagen [Internet]; October, 2019. Available from: https://www.qiagen.com/us/resources/resourcedetail?id=f02862d7-29df-4466-a457-ebde78beb891&lang=en. Accessed January 24, 2022.
   Google Scholar
• Fayyad-Kazan H, Bitar N, Najar M, et al. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med. 2013;11:31. doi:10.1186/1479-5876-11-31
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Birge RB, Kalodimos C, Inagaki F, Tanaka S. Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun Signal. 2009;7:13. doi:10.1186/1478-811X-7-13
   PubMed Web of Science ®Google Scholar
• Bassand K, Metzinger L, Naim M, et al. miR-126-3p is essential for CXCL12-induced angiogenesis. J Cell Mol Med. 2021;25(13):6032–6045. doi:10.1111/jcmm.16460
   PubMed Web of Science ®Google Scholar
• Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009;2(100):ra81. doi:10.1126/scisignal.2000610
   PubMed Web of Science ®Google Scholar
• Cho BS, Kim HJ, Konopleva M. Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside. Korean J Intern Med. 2017;32(2):248–257. doi:10.3904/kjim.2016.244
   PubMed Web of Science ®Google Scholar
• Yazdani Z, Mousavi Z, Moradabadi A, Hassanshahi G. Significance of CXCL12/CXCR4 ligand/receptor axis in various aspects of acute myeloid leukemia. Cancer Manag Res. 2020;12:2155–2165. doi:10.2147/CMAR.S234883
   PubMed Web of Science ®Google Scholar
• Will B, Vogler TO, Narayanagari S, et al. Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia. Nat Med. 2015;21(10):1172–1181. doi:10.1038/nm.3936
   PubMed Web of Science ®Google Scholar
• Li XM, Wang AM, Zhang J, Yi H. Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. Med Oncol. 2011;28(4):1054–1057. doi:10.1007/s12032-010-9637-6
   PubMed Web of Science ®Google Scholar
• Li Z, Lu J, Sun M, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A. 2008;105(40):15535–15540. doi:10.1073/pnas.0808266105
   PubMed Web of Science ®Google Scholar
• Lechman ER, Gentner B, Ng SWK, et al. miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells. Cancer Cell. 2016;29(4):602–606. doi:10.1016/j.ccell.2016.03.015
   PubMed Web of Science ®Google Scholar
• Qiu HY, Wang PF, Zhang M. A patent review of mTOR inhibitors for cancer therapy (2011-2020). Expert Opin Ther Pat. 2021;1–11. doi:10.1080/13543776.2021.1940137
   Web of Science ®Google Scholar
• Pappa T, Ahmadi S, Marqusee E, et al. Oncogenic mutations in PI3K/AKT/mTOR pathway effectors associate with worse prognosis in BRAF(V600E)-driven papillary thyroid cancer patients. Clin Cancer Res. 2021;27(15):4256–4264. doi:10.1158/1078-0432.CCR-21-0874
   PubMed Web of Science ®Google Scholar
• Li H, Zhao S, Shen L, et al. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer. Aging (Albany NY). 2021;13(10):13626–13643. doi:10.18632/aging.202891
   PubMedGoogle Scholar
• Bertacchini J, Frasson C, Chiarini F, et al. Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells. Adv Biol Regul. 2018;68:2–9. doi:10.1016/j.jbior.2018.03.001
   PubMedGoogle Scholar
• Dorrance AM, Neviani P, Ferenchak GJ, et al. Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia. Leukemia. 2015;29(11):2143–2153. doi:10.1038/leu.2015.139
   PubMed Web of Science ®Google Scholar
• Zhang L, Nguyen LXT, Chen YC, et al. Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance. Nat Commun. 2021;12(1):6154. doi:10.1038/s41467-021-26420-7
   PubMed Web of Science ®Google Scholar
• Xie S, Zhang Q, Zhao J, Hao J, Fu J, Li Y. MiR-423-5p may regulate ovarian response to ovulation induction via CSF1. Reprod Biol Endocrinol. 2020;18(1):26. doi:10.1186/s12958-020-00585-0
   PubMed Web of Science ®Google Scholar
• Wang RLG, Zhuang G, Sun S, Song Z, Song Z. Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer. Diagn Pathol. 2019;14(1). doi:10.1186/s13000-019-0831-3
   Web of Science ®Google Scholar
• Sun G, Ding X, Bi N, et al. MiR-423-5p in brain metastasis: potential role in diagnostics and molecular biology. Cell Death Dis. 2018;9(10):936. doi:10.1038/s41419-018-0955-5
   PubMed Web of Science ®Google Scholar
• Ling DJ, Chen ZS, Liao QD, Feng JX, Zhang XY, Yin TY. Differential effects of MTSS1 on invasion and proliferation in subtypes of non-small cell lung cancer cells. Exp Ther Med. 2016;12(2):1225–1231. doi:10.3892/etm.2016.3382
   PubMed Web of Science ®Google Scholar
• Yang S, Guo J, Zhou L, Xing H, Wang X, Dong C. miR-148b-3p, miR-337-5p and miR-423-5p expression in alveolar ridge atrophy and their roles in the proliferation and apoptosis of OMMSCs. Exp Ther Med. 2018;16(6):5334–5342. doi:10.3892/etm.2018.6850
   PubMed Web of Science ®Google Scholar
• Moussa Agha D, Rouas R, Najar M, et al. Identification of acute myeloid leukemia bone marrow circulating MicroRNAs. Int J Mol Sci. 2020;21(19):7065. doi:10.3390/ijms21197065
   PubMed Web of Science ®Google Scholar
• Xiong Q, Yang Y, Wang H, et al. Characterization of miRNomes in acute and chronic myeloid leukemia cell lines. Genomics Proteomics Bioinformatics. 2014;12(2):79–91. doi:10.1016/j.gpb.2014.02.001
   PubMedGoogle Scholar
• Dostalova Merkerova M, Krejcik Z, Votavova H, Belickova M, Vasikova A, Cermak J. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome. Eur J Hum Genet. 2011;19(3):313–319. doi:10.1038/ejhg.2010.209
   PubMed Web of Science ®Google Scholar